Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Baxter
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Gemifloxacin mesylate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for gemifloxacin mesylate and what is the scope of freedom to operate?

Gemifloxacin mesylate is the generic ingredient in two branded drugs marketed by Lg Chem Ltd and Orchid Hlthcare, and is included in two NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Gemifloxacin mesylate has fifteen patent family members in twelve countries.

There are two drug master file entries for gemifloxacin mesylate.

Summary for gemifloxacin mesylate
International Patents:15
US Patents:5
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 2
Bulk Api Vendors: 53
Patent Applications: 2,798
DailyMed Link:gemifloxacin mesylate at DailyMed
Synonyms for gemifloxacin mesylate
(+-)-7-(3-(Aminomethyl)-4-oxo-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, 7(sup 4)-(Z)-(O-methyloxime), monomethanesulfonate
(S,Z)-7-(3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
(Z)-7-(3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate
(Z)-7-(3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
1,4-Dihydro-1-cyclopropyl-4-oxo-6-fluoro-7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidine-1-yl]-1,8-naphthyridine-3-carboxylic acid
1,4-Dihydro-6-fluoro-1-cyclopropyl-4-oxo-7-[(3E)-4-(aminomethyl)-3-(methoxyimino)pyrrolidine-1-yl]-1,8-naphthyridine-3-carboxylic acid
1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, monomethanesulfonate
1,8-Naphthyridine-3-carboxylic acid, 7-(3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-
1,8-Naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-
1,8-Naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, monomethanesulfonate
175463-14-6
204519-64-2
204519-65-3
210353-52-9
210353-53-0
214346-11-9
214346-13-1
463G146
7-((4Z)-3-(Aminomethyl)-4-methoxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)naphthyridine-3-carboxylic acid monomethanesulfonate
7-(3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-[(4Z)-3-(aminomethyl)-4-methoxyimino-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoranyl-4-oxidanylidene-1,8-naphthyridine-3-carboxylic acid
7-[(4Z)-3-(aminomethyl)-4-methoxyimino-pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Mesilate
7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate
7-{3-Aminomethyl-4-[(Z)-methoxyimino]-pyrrolidin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
A812090
AB01563334_01
AKOS015907681
AKOS016010166
AM84619
AN-5497
ARB-FV0127
AS-13809
AX8131932
BDBM50178917
BRD-A40787240-066-02-0
BRD-A40787240-066-03-8
BSPBio_002308
C18H20FN5O4.CH4O3O
CAS-204519-65-3
CCG-39296
CHEBI:101853
CHEBI:53749
CHEMBL1200621
CHEMBL430
CS-4572
D02471
D08012
DB01155
DSSTox_CID_25948
DSSTox_GSID_45948
DSSTox_RID_81245
DTXSID3048495
DTXSID7045948
Factiv (TN)
Factive
Factive (TN)
Floxguard
Gemifioxacin
Gemifioxacin Mesylate
Gemifloxacin
Gemifloxacin (INN)
Gemifloxacin (mesylate)
Gemifloxacin [INN]
Gemifloxacin mesilate
Gemifloxacin mesylate (USAN)
Gemifloxacin mesylate [USAN]
Gemifloxacin mesylate, >=98% (HPLC)
Gemifloxacin; 7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-[1, 8]naphthyridine-3-carboxylic acid; 210353-56-3
Gemifloxacine
Gemifloxacino
Gemifloxacinum
Gemixa
HMS1922H08
HMS2093D22
HSDB 8027
HY-B1050
J10357
KB-212128
KB-278137
KB-293971
LB 20304
LB 20304a
LB-20304
LB-20304 Mesilate
LB-20304a
LS-186652
LS-186992
LS-187779
M63G146
MolPort-003-666-746
NCGC00095182-01
NCGC00095182-02
NCGC00178711-01
NCGC00178711-03
NSC-759252
NSC759252
Pharmakon1600-01505802
SB 265805
SB 265805S
SB-265805
SB-265805 Mesilate
SB-265805-S
SBI-0206906.P001
SCHEMBL13414391
SCHEMBL136633
SCHEMBL136827
SPECTRUM1505802
SR-05000001958
SR-05000001958-1
SR-05000001958-2
ST24047327
Tox21_111473
Tox21_111473_1
Paragraph IV (Patent) Challenges for GEMIFLOXACIN MESYLATE
Tradename Dosage Ingredient NDA Submissiondate
FACTIVE TABLET;ORAL gemifloxacin mesylate 021158 2008-03-04

US Patents and Regulatory Information for gemifloxacin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for gemifloxacin mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003   Start Trial   Start Trial
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003   Start Trial   Start Trial
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003   Start Trial   Start Trial
Lg Chem Ltd FACTIVE gemifloxacin mesylate TABLET;ORAL 021158-001 Apr 4, 2003   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Harvard Business School
Medtronic
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.